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Abstract
Background: Vitamin-D deficiency has been linked with impaired development in animal studies; however, the
evidence from human studies is scanty. Evidence as to whether vitamin-D deficiency during early childhood affects
growth is also limited and conflicting. We examined the extent to which vitamin-D deficiency (<10 ng/ml) is
associated with neurodevelopment and physical growth in young children.
Methods: We used data from a randomized controlled trial (RCT) of daily folic acid and/ or vitamin B12 supplementation
for six months in children aged 6 to 30 months conducted in Delhi, India. We measured vitamin-D status and
neurodevelopment by the Ages and Stages Questionnaire-3 (ASQ-3) at 12 to 36 months of age. Multiple logistic and linear
regressions were used to examine the association between vitamin-D deficiency at baseline and neurodevelopment
and growth 6 months follow-up.
Results: 25-hydroxy-vitamin-D (25OHD) concentration was measured at baseline for 960 (96%) children. Of these, 331
(34.5%) children were vitamin-D deficient. The total and subscale (except for the Personal social scale) ASQ-3 scores,
were not different between the vitamin-D deficient and non-deficient children. Vitamin-D deficiency was also not
associated with physical growth at baseline and at follow -up.
Conclusion: Our data do not support the hypothesis that vitamin-D deficiency is associated with poor growth and
neurodevelopment.
Trial registration: NCT00717730 and CTRI/2010/091/001090. Date of registration: 08 October, 2010
Keywords: Vitamin-D, ASQ-3, Neurodevelopment, Physical growth, Young north Indian children
Background
Vitamin-D deficiency is considered to be one of the
most common nutritional deficiencies and a commonly
undiagnosed medical condition in the world. [1] The
prevalence of vitamin-D deficiency is 50–90% in the In-
dian subcontinent. [2] Vitamin-D is primarily produced
in the skin after exposure to ultraviolet radiation and
less than 10% is derived from dietary sources. [3]
Poor maternal vitamin-D status during pregnancy has
been linked to impaired neurodevelopment among adult
offspring and to structural changes in the brain such as
enlarged lateral ventricles, thinner cortex, and more cell
proliferation in animal studies. [4, 5] Human studies have
shown that poor vitamin-D status prenatally is associated
with adverse neuropsychiatric outcomes including schizo-
phrenia and child autism. [6, 7] Two recent longitudinal
studies showed a link between maternal vitamin-D status in
early pregnancy and delayed neurocognitive development
including language impairment, mental development, and
psychomotor development in early childhood. [8, 9] To our
knowledge, there are few studies on the association be-
tween vitamin-D status in children and neurodevelopment.
Vitamin-D is required for normal calcification of the
growth plate and bone mineralization. [10] The major
role of vitamin-D in maintaining bone health is to en-
sure normal calcium and phosphate levels in the blood.
Children have higher calcium demands than adults; they
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require a positive calcium balance to assure adequate
calcium for the mineralization of growing bone. [11] It is
therefore important to ensure adequate vitamin-D status
in order to enhance normal calcification of the growth
plate and bone mineralization.
We undertook a randomized controlled trial (RCT) of
daily supplementation with folic acid and/or vitamin
B12 or placebo for six months in 6 to 30 months old
children and measured the 25OHD cocentration in the
blood specimens at baseline and at 6 months follow-up.
We took the opportunity to estimate the association be-
tween baseline and at 6 months follow -up vitamin-D
status and neurodevelopment measured by the Ages and
Stages Questionnaire-3 (ASQ-3) after 6 months as well
as the association between vitamin-D deficiency and
physical growth (wasting, stunting and underweight) at
baseline and 6 months later.
Methods
The study was conducted from January 2010 to February
2012 in the low-to-middle socioeconomic neighbor-
hoods of Tigri and Dakshinpuri in New Delhi, India.
The total population was around 300,000; details of the
population have been described previously [12]. The
current analysis has been done within the framework of
a randomized double-blind placebo-controlled trial
(NCT00717730 at https://clinicaltrials.gov/ct2/show/
NCT00717730) involving supplementation with folic
acid and/or vitamin B12 or placebo for six months to
1000 children who were 6 to 30 months old at enroll-
ment [12]. Vitamin-D status was available for 960 chil-
dren at baseline and in 243 at 6 months follow-up. For
baseline, our analysis for neurodevelopment is restricted
to the 401 children in whom ASQ-3 [13] was adminis-
tered, for physical growth to 960 children in whom an-
thropometry data were available at baseline and to 919
children in whom anthropometry data were available
6 months later. Of the 243 children, neurodevelopment
data were available for 92 children and anthropometry
data were available for all.
Assessment
Neurodevelopment was assessed 6 months after enroll-
ment using the ASQ-3 which is a developmental screen-
ing tool constructed in the USA. [13] The ASQ-3
consists of age-appropriate questionnaires, all containing
30 items divided into five subscales: Communication,
Gross motor, Fine motor, Problem-solving and Personal-
social, summing up to five subscale scores (range 0 to
60) and a total score (range 0 to 300). The construct and
convergent validity of the translated ASQ-3 forms for
the current setting were excellent, and our multiple
models were able to explain more than 30% of the vari-
ability of the ASQ-3 scores. [14]
Details of the Hindi translation and process of valid-
ation of ASQ-3, training and standardization methods
have been described previously. [15] Three trained field
supervisors administered the ASQ-3 directly to the child
at the study clinic in the presence of caregivers. The ex-
aminers elicited the relevant skills from the child during
sessions using standardized materials. The caregiver
served as an important contributor in supporting the
child, eliciting behaviors and gave relevant information
of the child’s development when necessary. During the
11 days of training, the field supervisors were standard-
ized in performing the procedure, and they reached a
high inter-observer agreement both during training and
in the 10% quality control checks throughout the study.
To assess the caregiver’s promotion of child develop-
ment two questions were selected from the standardized
assessment tool Home Observation for Measurement of
the Environment (HOME) that were asked the care-
givers during the session. [16] One question was on
“Mother’s belief that child’s behavior can be modified”
and one was on “Mother’s encouragement of develop-
mental advances”.
Trained field supervisors measured weight and length
at baseline and after six months of supplementation.
Weight was measured to the nearest 50 g using elec-
tronic scale (Digitron scale). Length was measured using
locally manufactured infantometers reading to the near-
est 0.1 cm.
Analytical procedures
Blood samples were obtained at baseline from all children;
3 mL blood was collected in an evacuated tube containing
EDTA (Becton Dickinson). The plasma was centrifuged at
~450×g at room temperature for 10 min, separated, and
transferred into storage vials and stored at −20 0 C until
analyzed. Plasma concentration of vitamin-D was mea-
sured by quantitative electro-chemiluminescence binding
assay, with detection of 25 OHD, the hydroxylated
forms of vitamin-D2 (Roche Diagnostics, Mannheim,
Germany) [17] at the Department of Biochemistry,
Christian Medical College, Vellore, India.
Statistical analysis
Proportions, means (SD) or medians (IQR) were calcu-
lated for categorical and continuous variables by
vitamin-D status at baseline. Though The Institute of
medicine concluded that for maximum bone health a
blood level should be at least 20 ng/mL and the Endo-
crine Society’s Practice Guidelines recommended for
maximum bone health a level should be above 30 ng/
mL, we considered vitamin-D deficiency was defined at
<10 ng/mL (25 nmol/L). [18] We also ran a sensitivity
analysis classifying baseline vitamin-D status as <10, 11–
20, 21–29 and > = 30 ng/mL.
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We used multiple regression and a “purposeful
selection of covariates method” to identify variables that
were associated with vitamin-D deficiency and our pre-
defined outcomes. [19, 20] These variables were used as
adjustment variables in the multiple models where
vitamin-D deficiency was the exposure variable. We also
examined whether the predefined associations were
modified by other variables using interaction terms (on
a multiplicative scale) in the multiple regression models.
Multiple linear and logistic regression analyses were
used to compare the total ASQ-3 and subscale-scores
between the vitamin-D deficient and the vitamin-D non-
deficient groups at baseline and at 6 months followup.
In logistic regression models the total and subscale
ASQ-3 scores were categorized at the 25th percentile. In
these models, we adjusted for age of child, mother’s
years of schooling, father’s years of schooling, log
transformed annual family income, family structure,
number of toys in the family, whether or not the
family owns books, number of children in the family,
hours of play with other children during the week,
mother’s belief that child’s behavior can be modified,
mother’s encouragement of developmental advances,
weight-for-height Z score, weight for-age Z scores
and intervention group.
We used multiple linear and logistic regression ana-
lyses to measure the association between vitamin-D defi-
ciency and childhood physical growth at baseline and at
6 months follow-up. In logistic regression models, phys-
ical growth was categorized as wasting (< −2 Z scores
weight-for-height/length), stunting (<−2 z score height/
length-for-age) and underweight (< −2 Z scores weight-
for-age). In the linear regression models, we used the Z
scores of weight-for-height/length (WHZ), height/
length-for-age (HAZ), weight-for-age (WAZ) as
dependent variables. In these models, we adjusted for
age, sex, breastfeeding status, family structure, log trans-
formed annual family income, mother’s years of school-
ing, father’s year of schooling, baseline level of vitamin
B12, folate and anemia status for baseline physical
growth as well as, intervention group (placebo, folic acid,
vitamin B12, or both) for 6 months later physical
growth.
Statistical analyses were performed using STATA ver-
sion 14 (Stata Corporation, College Station, TX).
We used generalized additive models in the statistical
software R version 3.1.2 (The R Foundation for Statis-
tical Computing, Vienna, Austria) to explore nonlinear
associations between the vitamin-D status at baseline
and HAZ score at baseline after adjustment for potential
confounders [21]. We also used generalized additive
models to explore nonlinear associations between
vitamin-D status at baseline and total ASQ-3 score after
6 months of follow - up.
Results
A total of 1000 children were included in the main trial.
Vitamin-D level was analyzed in baseline samples for
960 (96%) children. Of these, 331 (34.5%) were vitamin-
D deficient (<10 ng/ml). The mean (SD) and median
(IQR) of vitamin-D level were 14.82 (8.7) ng/ml and
13.15 (8.31, 19.2) ng/ml. The baseline characteristics of
the population by vitamin-D status are presented in
Table 1. Approximately half of the enrolled children
were boys and almost all (98%) were ever breast fed. Ap-
proximately 70% of the children were anemic
(Hb < 11 g/dl).
The mean (SD) of the total ASQ-3 and subscales
scores by vitamin-D status are shown in Table 2. The
overall ASQ-3 score was not significantly lower in the
vitamin-D deficient group [mean difference − 6.54 (95%
CI: -16.15 to 3.08)] compared to the vitamin-D non-
deficient group. The Personal social subscale score was
significantly lower in the vitamin-D deficient group
[mean difference − 2.63 (95% CI: -5.00 to −0.25)],
whereas the other subscale scores were not. There was
no interaction on a multiplicative scale between inter-
vention (folic acid and/or vitamin B12 or placebo) and
vitamin-D deficiency on the total ASQ-3 score or for the
subscales scores.
We repeated the analyses using logistic regression after
dichotomizing the outcomes at the 25th percentiles.
After adjusting for potential confounders, we found a
significant difference (OR: 1.63; 95% CI: 1.03 to 2.58) in
the Personal-social subscale. The overall ASQ-3 score
and the remaining subscales were not associated with
vitamin-D deficiency. (Table 3).
Tables 4 and 5 show the distribution of the propor-
tion of children stunted, wasted and underweight ac-
cording to vitamin-D status at baseline and 6 months
later respectively. At baseline in the vitamin-D defi-
cient group, the proportion of stunted, wasted and
underweight children was 35.4%, 10.6% and 30.5% re-
spectively. 6 months later, in the vitamin-D deficient
group the proportion of stunted, wasted and under-
weight children was 37.8%, 13.9% and 32.8% respect-
ively. Vitamin-D deficiency was not associated with
stunting nor wasting nor underweight at baseline or
6 months later in this population.
No substantial or significant differences were found
when we did these analyses using HAZ, WHZ and WAZ
scores as outcome variables both at baseline and
6 months later i.e. vitamin-D deficiency is not associated
with any of the physical growth parameters on a con-
tinuous scale.
We estimated vitamin D status at end study in only
243 children, and the prevalence of deficiency was
38.3%. Of the 243 children neurodevelopment data were
available for 92 children. None of the neurodevelopment
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outcomes (Total ASQ-3, sub scales of ASQ-3 i.e. Com-
munication, Gross motor, Fine motor, Problem - solving,
Personal- social), nor any of the grwoth outcomes were
significantly associated with vitamin D status after
6 months (Not shown in table).
We also did a sensitivity analysis by classifying baseline
vitamin-D status as <10, 11–20, 21–29 and > = 30 ng/
mL. 34.6% children were <10, 42.4% were 11–20, 17%
were 21–29 and 6% were above 30 ng/ml. None of the
neurodevelopment outcomes (Total ASQ-3, subscales of
ASQ-3 i.e. Communication, Gross motor, Fine motor, Prob-
lem solving, Personal- social) and growth outcomes (wast-
ing, stunting and underweight at baseline and end study)
were significantly associated with any of these quartiles.
The association between vitamin-D status at baseline
and HAZ score at baseline and total ASQ-3 score after
6 months are depicted in Figs 1 and 2. There was no
association.
Table 1 Baseline characteristics of vitamin-D deficient and non-deficient children aged 6–30 months included in the analysis
Characteristics n = 1000
Number of children for whom samples for vitamin-D were available at baseline 960 (96.0%)
Proportion of children
Deficient (< 10 ng/ml) 331 (34.5)
Non-deficient (≥ 10 ng/ml) 629 (65.5)
Deficient Non-deficient
n = 331 n = 629
Infant characteristics
Age at enrollment, months (mean, SD) 16.9 (7.1) 15.8 (7.0)
Boys 162 (48.9) 328 (52.2)
Ever breastfed 325 (98.2) 622 (98.9)
Anemia (Hb < 11 g/dl) 244 (73.7) 424 (67.4)
Folate, nmol/L (Median, IQR) 9.1 (6.1 to 16.7) 12.5 (6.9 to 21.8)
Vitamin B12, pmol/L (Median, IQR) 266 (181 to 406) 266 (172 to 410)
Socio-demographic characteristics
Mother’s age, years (Mean, SD) 26.3 (5.8) 25.6 (4.1)
Mother’s schooling, years (Median, IQR) 8 (5,10) 7 (0,10)
Literate mother 257 (77.6) 466 (74.1)
Father’s schooling, years (Median, IQR) 10 (7,12) 9 (6,12)
Annual family income, US dollar(Median, IQR)a 1108 (923to 2215) 1292 (923 to2123)
Figures are number (percentages) unless stated otherwise
a1 US Dollar = INR 65











Unadjusted Mean Diff (95% CI)
Total ASQ-3 229.98 (49.76) 236.52 (47.06) −6.54 (−16.15 to 3.08)
Subscale
Communication 49.04 (15.19) 49.26 (15.11) - 0.22 (−3.22 to 2.8)
Gross motor 46.36 (14.39) 48.29 (13.41) −1.93 (−4.69 to 0.82)
Fine motor 46.73 (14.90) 48.89 (12.09) −2.15 (−4.81 to 0.50)
Problem-solving 46.42 (13.97) 46.03 (13.45) 0.39 (−2.33 to 3.12)
Personal social 46.42 (12.04) 49.05 (11.84) −2.63 (−5 to −0.25)*
*p < 0.05
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Discussion
Except for the Personal - social scale, we did not find
any significant differences in the total ASQ-3 and sub-
scale scores between vitamin-D deficient and non-
deficient children. Nor did we find any association be-
tween growth indices and vitamin D deficiency.
Our findings are consistent with those from a re-
cently conductedcohort study in India, where
vitamin-D status was not associated with the gross
motor subscale of ASQ-3 among school- aged chil-
dren [22]. A recent prospective study also suggests
an inverted-U–shaped relation between neonatal
vitamin-D status and neurocognitive development in
toddlers [23]. Recent studies have shown an association
between prenatal vitamin-D deficiency with delayed lan-
guage development in early childhood [24, 25]. However,
the association between vitamin-D deficiency and the
Personal social subscale may very well be a chance
finding considering the number of outcomes exam-
ined. It should also be noted that the personal social
scores is the domain with poorest psychometric
properties. [15]
The ASQ-3 is a screening tool for the assessment of
developmental delay constructed in the US with binary
cut-offs. It has however been used to measure develop-
mental status on a continuous scale in the present study
as in several other studies. [13] Alpha values indicated
questionable internal consistency in a few subscales and
age categories. Poor internal consistency can be due to
constant items (lack of variability of the responses) or
random error which may result in false negative results
(type II error). However, in another publication from this
study we also found that the ASQ-3 scores were associated
with linear and ponderal growth, the incidence of diar-
rhea and pneumonia, as well as socioeconomic status
and stimulation and learning opportunities. In fact, these
variables explained more than 30% of the variability of
the ASQ scores which demonstrates that the translated
ASQ-3 test had good convergent validity. [14] Thus, the
lack of findings of an association between vitamin-D and
Table 3 Odds Ratios for the lower quartile of total ASQ-3 and subscale scores compared with Non-deficient vitamin-D status (≥
10 ng/ml) adjusting for confoundersa
Non-Deficient
(Vitamin-D status ≥ 10 ng/ml)
Deficient
(Vitamin-D status < 10 ng/ml)
OR OR 95% CI
Total ASQ-3 1 1.36 0.79 to2.31
Subscale
Communication 1 1.58 0.97to 2.59
Gross motor 1 1.27 0.80 to 2.03
Fine motor 1 1.31 0.81to 2.11
Problem-solving 1 1.33 0.84to 2.11
Personal - social 1 1.63 1.03to 2.58*
*p < 0.05
aAdjusted for: age of child, mother’s years of schooling, father’s years of schooling, log transformed annual family income, family structure, number of toys in the
family, whether or not the family owns books, number of children in the family, hours of play with other children during the week, mother’s belief that child’s
behavior can be modified, mother’s encouragement of developmental advances, weight-for-height Z score, weight for-age Z scores, anemia status at baseline and
intervention group












HAZ −1.56 (1.24) −1.63 (1.16) .05 (−0.10 to 0.20)
WHZ −0.86 (0.92) −0.89 (0.94) .02 (−0.10 to 0.14)
WAZ −1.46 (1.06) −1.52 (1.05) .03 (−0.10 to 0.17)
Adjusted OR (95% CI)a
Stunted, n (%) 117 (35.4) 233 (37.0) 0.84 (0.63 to 1.13)
Wasted, n (%) 35 (10.6) 68 (10.8) 0.99 (0.64 to 1.54)
Underweight, n (%) 101 (30.5) 197 (31.3) 0.91 (0.67 to 1.23)
aAdjusted for: age, sex, breastfeeding status, log transformed annual family income, family structure, mother’s years of schooling, father’s years of schooling,
baseline levels of vitamin B12, folate, anemia status at baseline
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ASQ-3 scores is probably not due to poor psychometric
properties of the test. In the translated ASQ-3 version, the
standardized alphas for the total ASQ-3 scores were
strong, indicating an overall acceptable internal
consistency.
Type II errors can also be due to low sample size,
negative confounding, and/or weaknesses with the im-
munological vitamin –D assay. We used an immuno-
logical method to measure vitamin-D concentration.
It should be noted that immunoassays can overesti-
mate 25OHD [26] because it is lipophilic which
makes it vulnerable to matrix effects in the protein
binding assays. [27]
We found no association between vitamin-D defi-
ciency and physical growth at baseline and 6 months
later. Similar findings have been described in pre-school
children in Nepal and HIV exposed but uninfected
infants in Africa, where vitamin-D deficiency was not as-
sociated with stunting and underweight, although wasted
children have been found to be more commonly vita-
min- D deficient. [28, 29] However, a recent trial in India
showed that weekly administration of 1 RDA of vitamin-
D supplementation for six months among LBW infants
significantly increased weight and length, and decreased
the proportion of children with stunted growth. [30] In
addition, an observational study of Canadian infants
found higher vitamin - D concentrations during infancy
to 3 years of age were associated with leaner body com-
position. [31]
Although the major role of vitamin-D in maintaining
bone health is to ensure normal calcium and phosphate
levels in the blood, [32] we did not find any association
between vitamin-D deficiency and ponderal or linear
growth.












HAZ −1.69 (1.17) −1.81 (1.12) 0.11 (−0.20 to 0.43)
WHZ −0.93 (0.97) −0.95 (0.92) 0.20 (−0.05 to 0.46)
WAZ −1.55 (1.08) −1.62 (1.00) 0.20 (−0.06 to 0.47)
Adjusted
OR (95% CI)a
Stunted, n (%) 122 (37.8) 265 (44.5) 0.81 (0.61 to 1.07)
Wasted, n (%) 45 (13.9) 67 (11.2) 1.35 (0.90 to 2.04)
Underweight, n (%) 106 (32.8) 209 (35.1) 0.97 (0.72 to 1.29)
aAdjusted for: age, sex, breastfeeding status, log transformed annual family income, family structure, mother’s years of schooling, father’s years of schooling,








Fig. 1 Associations between vitamin-D level at baseline and HAZ score at baseline. The graphs were constructed using generalized additive
models in R, the solid line depicts the association of vitamin-D level at baseline and HAZ score at baseline. The shaded area spans the 95% confidence
interval of this association
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There may be deficiencies other growth-limiting
macro and micronutrients such as calcium, zinc, vitamin
–B12 etc. Poor quality of food i.e. lower proportion of
animal source protein may also contribute to poor
growth. The influence of vitamin D might be small in
the light of other growth limiting factors.
To our knowledge this is the first analysis to examine
the association between vitamin-D status and several do-
mains of the ASQ-3. The strengths of our study are that
the data are from a well conducted study with very low
attrition rates. [33] More comprehensive assessment
tools, such as the Bayley scales, or tools for social emo-
tional functioning, could have added a broader picture
of the children’s skills and abilities yielding different re-
sults. There was a need for follow up assessments since
6 months may not be sufficient to assess the associations
between vitamin- D status and development and growth.
Finally, more advanced neuroimaging techniques may
have identified unique changes to the developing brain
in early childhood that could have been linked to
vitamin-D deficiency.
Conclusion
The results from this analysis do not support that
vitamin-D deficiency in early childhood is important for
growth and neurodevelopment.
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Fig. 2 Associations between vitamin-D level at baseline and total ASQ-3 score after 6 months of follow up. The graphs were constructed using generalized
additive models in R, the solid line depicts the association of vitamin-D level at baseline and total ASQ-3 score. The shaded area spans the
95% confidence interval of this association
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